Key result
A single dose of cyclophosphamide in adult mice led to a persistent decrease in treadmill running time at 6 weeks compared to baseline (25.7 vs. 49.0 min, P=0.0012) and sustained mitochondrial dysfunction.
Why the study?
Does cyclophosphamide reduce physical performance and in vivo mitochondria function in a mouse model?
Does cyclophosphamide reduce physical performance and in vivo mitochondria function in a mouse model?
A single dose of cyclophosphamide in mice leads to persistent exercise intolerance and in vivo mitochondrial dysfunction at 6 weeks, which does not appear linked to persistent oxidative stress.
Answers are grounded in this paper and cite their sources.
May warrant caution for persistent functional cardiotoxicity with cyclophosphamide; leaves open human translation and mechanisms.
Fatigue is the symptom most commonly reported by long-term cancer survivors and is increasingly recognized as related to skeletal muscle dysfunction. Traditional chemotherapeutic agents can cause acute toxicities including cardiac and skeletal myopathies. To investigate the mechanism by which chemotherapy may lead to persistent skeletal muscle dysfunction, mature adult mice were injected with a single cyclophosphamide dose and evaluated for 6 weeks. We found that exposed mice developed a persistent decrease in treadmill running time compared to baseline (25.7±10.6 vs. 49.0±16.8 min, P = 0.0012). Further, 6 weeks after drug exposure, in vivo parameters of mitochondrial function remained below baseline including maximum ATP production (482.1 ± 48.6 vs. 696.2 ± 76.6, P = 0.029) and phosphocreatine to ATP ratio (3.243 ± 0.1 vs. 3.878 ± 0.1, P = 0.004). Immunoblotting of homogenized muscles from treated animals demonstrated a transient increase in HNE adducts 1 week after exposure that resolved by 6 weeks. However, there was no evidence of an oxidative stress response as measured by quantitation of SOD1, SOD2, and catalase protein levels. Examination of mtDNA demonstrated that the mutation frequency remained comparable between control and treated groups. Interestingly, there was evidence of a transient increase in NF-ĸB p65 protein 1 day after drug exposure as compared to saline controls (0.091±0.017 vs. 0.053±0.022, P = 0.033). These data suggest that continued impairment in muscle and mitochondria function in cyclophosphamide-treated animals is not linked to persistent oxidative stress and that alternative mechanisms need to be considered.
No takes yet. Share an insight, caveat, or question.
Crouch et al. (2017) studied Chemotherapy late effects (n=20). Cyclophosphamide vs. Normal saline solution was evaluated on Treadmill running time at 6 weeks compared to baseline (p=0.0012). A single dose of cyclophosphamide in adult mice led to a persistent decrease in treadmill running time at 6 weeks compared to baseline (25.7 vs. 49.0 min, P=0.0012) and sustained mitochondrial dysfunction.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: